Search results for "Open"

showing 10 items of 3963 documents

The Role of Imaging Biomarkers in the Assessment of Sarcopenia

2020

Background: The diagnosis of sarcopenia through clinical assessment has some limitations. The literature advises studies that include objective markers along with clinical assessment in order to improve the sensitivity and specificity of current diagnostic criteria. The decrease of muscle quality precedes the loss of quantity, so we studied the role magnetic resonance imaging biomarkers as indicators of the quantity and quality of muscle in sarcopenia patients. Methods: a cross-sectional analysis was performed to analyze what MR-derived imaging parameters correlate better with sarcopenia diagnostic criteria in women of 70 years of age and over (independent walking and community-dwelling wom…

medicine.medical_specialtyClinical BiochemistryMuscle massArticle030218 nuclear medicine & medical imagingFat massIndependent walkingsarcopeniaolder people03 medical and health sciences0302 clinical medicineInternal medicinemagnetic resonance imagingMedicineStage (cooking)lcsh:R5-920medicine.diagnostic_testbusiness.industryMagnetic resonance imagingmedicine.diseaseSpanish populationSarcopeniabiomarkerBiomarker (medicine)sarcopenia; magnetic resonance imaging; biomarker; older peoplelcsh:Medicine (General)businesshuman activities030217 neurology & neurosurgeryDiagnostics
researchProduct

ADAMTS13 and VWF activities guide individualized caplacizumab treatment in patients with aTTP

2020

Abstract Introduction of the nanobody caplacizumab was shown to be effective in the treatment of acquired thrombotic thrombocytopenic purpura (aTTP) in the acute setting. The official recommendations include plasma exchange (PEX), immunosuppression, and the use of caplacizumab for a minimum of 30 days after stopping daily PEX. This study was a retrospective, observational analysis of the use of caplacizumab in 60 patients from 29 medical centers in Germany. Immunosuppressive treatment led to a rapid normalization of ADAMTS13 activities (calculated median, 21 days). In 35 of 60 patients, ADAMTS13 activities started to normalize before day 30 after PEX; in 11 of 60 patients, the treatment was…

medicine.medical_specialtyClinical Trials and Observationsmedicine.medical_treatmentMedizinADAMTS13 Protein030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineVon Willebrand factorFibrinolytic AgentsInternal medicinehemic and lymphatic diseasesvon Willebrand FactormedicineHumansIn patientRetrospective StudiesAcquired Thrombotic Thrombocytopenic PurpurabiologyPurpura Thrombotic Thrombocytopenicbusiness.industryImmunosuppressionRetrospective cohort studyHematologySingle-Domain AntibodiesADAMTS13Cardiovascular and Metabolic Diseases030220 oncology & carcinogenesisbiology.proteinBiomarker (medicine)Caplacizumabbusiness
researchProduct

The Principles of Quantum Theory

2013

This chapter develops the formal framework of quantum mechanics: the mathematical tools, generalization and abstraction of the notion of state, representation theory, and a first version of the postulates on which quantum theory rests.

medicine.medical_specialtyComputer scienceGeneralizationQuantum dynamicsHilbert spaceRelationship between string theory and quantum field theoryAbstraction (mathematics)symbols.namesakeOpen quantum systemQuantum stateQuantum mechanicssymbolsQuantum nanosciencemedicine
researchProduct

Protective Role of Conization Before Radical Hysterectomy in Early-Stage Cervical Cancer: A Propensity-Score Matching Study.

2021

Purpose: The purpose of this study was to assess the prognostic role and the perioperative outcomes of conization performed before radical hysterectomy in early-stage cervical carcinoma. Methods: This multicenter, retrospective observational cohort study included patients with FIGO 2009 stage IB1 cervical carcinoma treated with radical hysterectomy between June 2004 and June 2019. Patients were divided into two groups according to conization before radical surgery. One-to-one case–control matching was used to adjust the baseline characteristics. Results: A total of 332 patients were included after propensity matching (166, 50% in each group). Twenty-four of 166 (14.4%) and 142 of 166 (85.6%…

medicine.medical_specialtyConizationUterine Cervical NeoplasmsHysterectomy03 medical and health sciences0302 clinical medicineMedicineHumansRisk factorStage (cooking)Radical surgeryRadical HysterectomyNeoplasm StagingRetrospective StudiesCervical cancerbusiness.industryPerioperativemedicine.diseaseSurgeryNeoplasm RecurrenceSettore MED/40 - GINECOLOGIA E OSTETRICIALocalOncology030220 oncology & carcinogenesisPropensity score matchingCervical cancer030211 gastroenterology & hepatologySurgeryFemaleNeoplasm Recurrence LocalbusinessCohort studyAnnals of surgical oncologyREFERENCES
researchProduct

Home-Based Resistance Training for Older Subjects during the COVID-19 Outbreak in Italy: Preliminary Results of a Six-Months RCT.

2020

Background. The aim of this study was to evaluate the effect of a six-month home-based resistance-training program on muscle health and physical performance in healthy older subjects during the unique condition of home confinement caused by the COVID-19 pandemic. Methods. This was a randomized-controlled study that enrolled older participants that were allocated to either an experimental group performing the six-months exercise prescription (EXE) or a control group (CON). At the beginning (PRE), and after 6 months (POST), participants were assessed for muscle strength, balance, gait assessment and body composition by dual energy X-ray absorptiometry and magnetic resonance imaging. Normality…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Health Toxicology and Mutagenesislcsh:MedicineArticlelaw.inventionsarcopenia03 medical and health sciences0302 clinical medicinerisk of fallRandomized controlled triallawInternal medicineEpidemiologymedicineHumansmagnetic resonance imaging030212 general & internal medicineMuscle StrengthPandemicsBalance (ability)AgedAged 80 and overDXAexercisebusiness.industrylcsh:RagingPublic Health Environmental and Occupational HealthOutbreakCOVID-19Resistance TrainingMiddle Agedmedicine.diseaseItalySarcopeniaGait analysisCommunicable Disease ControlBody CompositionbusinessExercise prescription030217 neurology & neurosurgeryInternational journal of environmental research and public health
researchProduct

PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC

2021

The current COVID-19 pandemic requires revisiting our current approach to major blood disorders, including ITP (Immune Thrombocytopenia), stirring  up the production of several disease-specific practical guidelines. This report describes an updated version of consensus-based practical guidelines on the management of ITP, adapted to the Italian health system and social context.  It highlights the role of the hematologist in offering guidance for choosing differentiated approaches in relation to specific circumstances and is intended to provide them with a useful tool for sharing the decision-making process with their patients.
 Probably, the greatest risk to avoid for a patient with sus…

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)business.industrymedicine.medical_treatmentSplenectomySocial environmentHematology030204 cardiovascular system & hematologyImmune thrombocytopenia03 medical and health sciencesTherapeutic approach0302 clinical medicineInfectious DiseasesBlood Disorderhemic and lymphatic diseasesPandemicmedicine030212 general & internal medicineHematologistIntensive care medicinebusinessMediterranean Journal of Hematology and Infectious Diseases
researchProduct

Cost-effectiveness analysis of robot-assisted vs. open partial nephrectomy

2017

Background The cost-effectiveness of robot-assisted partial nephrectomy (RAPN) vs. the open procedure is not established. Methods We estimated in-hospital complications and the cost of RAPN vs. open partial nephrectomy (OPN) using an economic model. Costs incurred both intraoperatively and in hospital were considered. US data were extracted from existing literature. Results Mean in-hospital costs were $14,824 (95% CI $13,368-$16,898) for RAPN and $15,094 (95% CI $13,491-$17,140) for OPN. Complications after RAPN occurred in 23.3% (95% CI 20.0-25.8%) and after OPN in 36.1% (95% CI 35.6-36.6%) of the patients. In a sensitivity analysis, limited centre experience was associated with relevant i…

medicine.medical_specialtyCost-Benefit Analysismedicine.medical_treatment030232 urology & nephrologyBiophysicsNephrectomy03 medical and health sciencesPostoperative Complications0302 clinical medicineRobotic Surgical ProceduresmedicineHumansOpen partial nephrectomyHospital CostsComputer-assisted surgerybusiness.industryDecision TreesPerioperativeCost-effectiveness analysisNephrectomyComputer Science ApplicationsSurgeryModels EconomicTreatment Outcome030220 oncology & carcinogenesisSurgeryLower costbusinessThe International Journal of Medical Robotics and Computer Assisted Surgery
researchProduct

Toxicity Profile and Adherence to the Pharmacotherapeutic Regimen of Gemcitabine–carboplatin in Non-small Cell Lung Cancer

2011

Objective: To analyse the relationship between doses of gemcitabine---carboplatin (GEM-CARBO) administered and incidence and level of haematological and renal toxicity, and the adherence to the treatment in patients with non-small cell lung cancer. Methods: Retrospective study, which lasted for 37 months. We were able to obtain the minimum set of data needed to carry out the follow-up with the help of Farmis-Oncofarm ® software and the medical and pharmacotherapeutic records. The haematological toxicity was assessed in accordance with the Common Toxicity Criteria 3.0. Renal toxicity was evaluated using serum creatinine levels and creatinine clearance. Results: Thirty-one patients were inclu…

medicine.medical_specialtyCreatininebusiness.industryRenal functionNeutropeniamedicine.diseaseGemcitabineCarboplatinSurgerychemistry.chemical_compoundRegimenchemistryInternal medicineToxicitymedicinebusinessLung cancermedicine.drugFarmacia Hospitalaria (English Edition)
researchProduct

Immunochemotherapy with Fludarabine (F), Cyclophosphamide (C), and Rituximab (R) (FCR) Versus Fludarabine and Cyclophosphamide (FC) Improves Response…

2008

Abstract Introduction: Previous phase II studies have suggested that a combination of FCR may increase the outcome of both untreated and relapsed CLL pts. In order to validate this concept the German CLL study group (GCLLSG) initiated a multicentre, multinational phase III trial, CLL8, to evaluate the efficacy and tolerability of FCR versus FC for the first-line treatment of pts with advanced CLL. Methods and Patients: 817 pts with good physical fitness as defined by a cumulative illness rating scale (CIRS) score (Extermann et al., JCO 1998) of up to 6 and a creatinine clearance (cr cl) □d 70 ml/min were enrolled between July 2003 and March 2006. Pts were randomly assigned to receive 6 cour…

medicine.medical_specialtyCyclophosphamideImmunologychemical and pharmacologic phenomenaNeutropeniaBiochemistryGastroenterology03 medical and health sciences0302 clinical medicineChemoimmunotherapyInternal medicinemedicineProgression-free survivalLeukopeniabusiness.industryCell BiologyHematologymedicine.disease3. Good healthSurgeryFludarabineTolerability030220 oncology & carcinogenesisConcomitantmedicine.symptombusiness030215 immunologymedicine.drugBlood
researchProduct

A phase I-II study of cyclophosphamide, epidoxorubicin, levofolinic acid/5-fluorouracil and recombinant human granulocyte colony stimulating factor i…

1994

Thirty patients with measurable metastatic breast carcinoma were treated with a combination of cyclophosphamide 600 mg/m2 on day 1, levofolinic acid 100 mg/m2 plus 5-fluorouracil 375 mg/m2 on days 1-3, and epidoxorubicin (EDXR) in three refracted doses on days 1-3 with G-CSF rescue for 10 days. In the phase I part of the study, groups of 3 patients received EDXR 20, 25, 30, 35, and 40 mg/m2/day until the dose limiting toxicity (DLT) was reached. At the dose of 40mg/m2/day prolonged grade 4 leukopenia, severe proctitis, and grade 3 diarrhea represented the DLT. All subsequent partients were treated at the maximal tolerated dose of EDXR (35 mg/m2/day). In the group of 18 patients treated at 3…

medicine.medical_specialtyCyclophosphamideSettore MED/06 - Oncologia Medicamedicine.medical_treatmentLeucovorinBreast NeoplasmsGastroenterologyDrug Administration ScheduleInternal medicineAntineoplastic Combined Chemotherapy ProtocolsGranulocyte Colony-Stimulating FactormedicineCarcinomaHumansRadiology Nuclear Medicine and imagingCyclophosphamideEpirubicinChemotherapyLeukopeniabusiness.industryCarcinomaHematologyGeneral MedicineLeukopeniaMiddle Agedmedicine.diseaseRecombinant ProteinsSurgeryGranulocyte colony-stimulating factorSettore MED/18 - Chirurgia GeneraleRegimenTreatment OutcomeOncologyFluorouracilToxicityFemaleFluorouracilmedicine.symptombusinessmedicine.drugActa oncologica (Stockholm, Sweden)
researchProduct